EC
JNJ icon

Eleva Capital’s Johnson & Johnson JNJ Stock Holding History

Eleva Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.44M Buy
+5,446
New +$1.44M 1.27% 18

Other funds holding JNJ

FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
VCM
Violich Capital Management San Francisco, California $927M AUM 28.93% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Eleva Capital's JNJ Position: Q3 2026 in Review

Eleva Capital opened a new position in Johnson & Johnson (JNJ) in Q3 2026: 5,446 shares worth $1.44M. The stake represents 1.27% of the portfolio and ranks #18 among its holdings.

69 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Eleva Capital held 5,446 shares of Johnson & Johnson worth $1.44M as of Q3 2026.
  • Johnson & Johnson was a new Eleva Capital position in Q3 2026.
  • Johnson & Johnson made up 1.27% of Eleva Capital's portfolio in Q3 2026, its #18 holding.
  • 69 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.